Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Protein-protein Interfaces02:04

Protein-protein Interfaces

14.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.4K
Ligand Binding Sites02:40

Ligand Binding Sites

14.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.8K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.7K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systematic Modeling of Covalent Inhibitors of SARS-CoV-2 Main Protease and Its Mutants.

ACS catalysis·2026
Same author

Computational Insights into the Activation Mechanism of CXCR4: Implications for the Design of Small Molecule Agonists.

Journal of the American Chemical Society·2026
Same author

Sunscreen Efficacy Against UVA1- And Visible Light-Induced Skin Pigmentation Is Influenced by Ancestry.

Photodermatology, photoimmunology & photomedicine·2026
Same author

Arecoline as a Novel Scaffold Targeting the ATAD2 Bromodomain for Cell Cycle Modulation.

Pharmaceutics·2026
Same author

Enhanced Whitening Effect of the Formulations via Inhibition of Tyrosinase Activity by Combination of 4-n-Butylresorcinol, Licochalcone A and Glabridin at an Optimal Ratio.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·2026
Same author

Combating Antiviral Drug Resistance: A Multipronged Strategy.

Accounts of chemical research·2026

Related Experiment Video

Updated: Jan 8, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.6K

Semi-inductive dataset construction and framework optimization for practical drug target interaction prediction with

Yigang Chen1,2,3, Xiang Ji1,2, Ziyue Zhang1,2

  • 1School of Medicine, The Chinese University of Hong Kong, Shenzhen, Longgang District, Shenzhen, Guangdong, China.

Nature Communications
|December 13, 2025
PubMed
Summary
This summary is machine-generated.

We introduce SCOPE-DTI, a novel framework enhancing drug-target interaction (DTI) prediction with a large dataset and advanced deep learning. This approach improves accuracy and accelerates drug discovery by overcoming data limitations.

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.5K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.1K

Related Experiment Videos

Last Updated: Jan 8, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.6K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.5K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.1K

Area of Science:

  • Computational Biology
  • Pharmacology
  • Artificial Intelligence

Background:

  • Deep learning methods for drug-target interaction (DTI) prediction show promise but face limitations in data diversity and model complexity.
  • Existing benchmarks often lack sufficient data volume and balance, hindering real-world applicability.

Purpose of the Study:

  • To develop a unified framework, SCOPE-DTI, that addresses limitations in DTI prediction by integrating a large-scale, balanced dataset with advanced deep learning models.
  • To enhance the accuracy and efficiency of DTI prediction for accelerating drug discovery.

Main Methods:

  • Constructed SCOPE-DTI from 13 public repositories, creating a dataset up to 100-fold larger than common benchmarks.
  • Employed a SCOPE model integrating 3D protein and compound representations, graph neural networks, and bilinear attention mechanisms.
  • Developed a user-friendly interface and database for SCOPE-DTI.

Main Results:

  • The SCOPE model demonstrated superior performance across various DTI prediction tasks, outperforming state-of-the-art methods.
  • Experimental validation identified anticancer targets for two bioactive natural compounds, confirming the framework's effectiveness.
  • The integrated dataset and model significantly improved the prediction of cross-domain interaction patterns.

Conclusions:

  • SCOPE-DTI offers a comprehensive solution for DTI prediction by providing extensive data, sophisticated modeling, and accessible tools.
  • The framework effectively accelerates drug discovery research by overcoming data scarcity and model complexity challenges.
  • This work facilitates the identification of novel drug targets and the development of new therapeutics.